Skip to main content

Table 3 Summary of participant characteristics

From: A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis

Reference Dx Sample (n) Age (years, mean (SD) Sex, female (%) Illness duration BMI (kg m−2), mean (SD) Weight (kg), mean (SD)
CFS HC CFS HC CFS HC CFS HC CFS HC
Armstrong et al. Canadian (2003) 34 25 34.9 (1.8) 33.0 (1.6) 100% 100% NR 24.0 (0.81) 23.0 (0.74) NR
Frémont et al. Fukuda (1994) Belgian: 18
Norwegian: 17
Belgian: 19
Norwegian: 17
38.5 (13)
41 (12.5)
41 (12.6)
45 (19)
83%
88%
79%
82%
Belgian: 7 ± 4 years
Norwegian: 12 ± 9 years
NR NR
Giloteaux et al. Fukuda (1994) 49 39 50.2 (12.6) 45.5 (9.9) 78% 77% NR 25.5 (4.9) 27.1 (6.1) NR
Mandarano et al. Fukuda (1994) Taxa abundance comparisons 17
Diversity subgroup 11
Taxa abundance comparisons 17
Diversity subgroup 10
52 (11.9)
54 (11.6)
44.6 (10.9)
43.6 (13.6)
76%
64%
94%
90%
NR 26.8 (4.7)
26.2 (4.9)
27.4 (4.5)
27.7 (5.2)
NR
Rao et al. Canadian (2003) CFS placebo: 16
CFS treatment: 19
NR 77% NR NR NR
Sheedy et al. Holmes (1988) Fukuda (1994) Candain (2003) 108 177 NR NR NR NR NR
Shukla et al. Fukuda (1994) 10 10 48.6 (10.5) 46.5 (13.0) 80% 80% NR 23.9 (4.3) 24.6 (3.3) 68.3 (13.7) 65.5 (8.3)
  1. Dx diagnostic criteria, CFS/ME chronic fatigue syndrome/myalgic encephalomyelitis, HC healthy control, BMI body mass index, SD standard deviation, NR not reported